实用肿瘤学杂志 ›› 2011, Vol. 25 ›› Issue (6): 579-583.doi: 10.3969/j.issn.1002-3070.2011.06.021

• 综述 • 上一篇    下一篇

结直肠癌中KRAS基因突变及其检测方法概述

王东亮1, 张艳桥1, 2   

  1. 1.哈尔滨医科大学附属第三医院内八科(哈尔滨 150081);
    2.哈尔滨医科大学肿瘤防治研究所
  • 收稿日期:2011-11-17 出版日期:2011-12-28 发布日期:2014-12-02
  • 通讯作者: 张艳桥,E-mail:wang.dong.liang@hotmail.com
  • 作者简介:王东亮,男,(1981-),博士在读,住院医师,从事于消化道肿瘤的化疗、分子靶向治疗及生物治疗

A review of KRAS gene mutation in colorectal cancer and its testing methods

WANG Dongliang,ZHANG Yanqiao   

  1. 1.Department of Gastrointestinal Medical Oncology,The Third Affiliated Hospital of Harbin Medical University,Harbin 150081;
    2.Prevention and Control Center of Tumor,Harbin Medical University,Harbin 150081
  • Received:2011-11-17 Online:2011-12-28 Published:2014-12-02

摘要: 结直肠癌(Colorectal Cancer,CRC)是世界上发病率最高的恶性肿瘤之一。CRC的发生与细胞的跨膜信号转导系统功能异常有关,目前已经明确Ras/Raf/MAPK级联反应通路在其中起到很重要的作用。在CRC中,KRAS基因突变十分常见,KRAS基因的突变使信号转导通路下游各种基因的激活不再依赖于表皮生长因子受体(Epidermal Growth Factor Receptor,EGFR)的启动,这对CRC的发生、发展、治疗与预后起着非常重要的作用。因此,在临床工作中,检测KRAS基因突变情况显得尤为重要,这也对检测技术及其准确性提出了更高的要求。本文对KRAS在CRC中的作用、机制及其突变的概率、检测方法做一简要综述。

Abstract: Colorectal cancer is one of the most common malignancies in the world.Abnormal function of intestinal cells′ transmembrane signal transduction systems is associated with colorectal carcinogenesis,of which Ras/Raf/Mitogen-activated protein kinase(MAPK)cascade has been definitely and significantly involved.KRAS gene mutation leads the epidermal growth factor receptor(EGFR)′s initiation unnecessary for the activation of various genes in the downstream signal transduction pathways,which plays a major role in colorectal cancer′s genesis,progress therapy and prognosis.Therefore,testing KRAS gene status is essential in the clinical work,which demands for more precise of these processes.We sum up KRAS gene′s role in colorectal cancer and its mechanism,mutant incidence and testing methods.

中图分类号: